Show simple item record

dc.contributor.authorDe Laere, B
dc.contributor.authorRajan, P
dc.contributor.authorGrönberg, H
dc.contributor.authorDirix, L
dc.contributor.authorLindberg, J
dc.contributor.authorCORE-ARV-CTC and ProBIO Investigators
dc.date.accessioned2019-07-22T14:16:06Z
dc.date.available2019-03-05
dc.date.available2019-07-22T14:16:06Z
dc.date.issued2019-05-02
dc.identifier.citationDe Laere B, Rajan P, Grönberg H, Dirix L, Lindberg J, for the CORE-ARV-CTC and ProBIO Investigators. Androgen Receptor Burden and Poor Response to Abiraterone or Enzalutamide in TP53 Wild-Type Metastatic Castration-Resistant Prostate Cancer. JAMA Oncol. Published online May 02, 20195(7):1060–1062. doi:10.1001/jamaoncol.2019.0869en_US
dc.identifier.issn2374-2437
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/58611
dc.languageeng
dc.language.isoenen_US
dc.publisherAmerican Medical Associationen_US
dc.relation.ispartofJAMA Oncol
dc.titleAndrogen Receptor Burden and Poor Response to Abiraterone or Enzalutamide in TP53 Wild-Type Metastatic Castration-Resistant Prostate Cancer.en_US
dc.typeArticleen_US
dc.identifier.doi10.1001/jamaoncol.2019.0869
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/31046065en_US
pubs.notesNot knownen_US
pubs.publication-statusPublished onlineen_US
dcterms.dateAccepted2019-05-02
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US
qmul.funderSam68 and hnRNPA2 in prostate cancer::Cancer Research UKen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record